FI57421C - Foerfarande foer framstaellning av ett preparat ur maenniskoblodplasma med blodets koagulation befraemjande verkan - Google Patents

Foerfarande foer framstaellning av ett preparat ur maenniskoblodplasma med blodets koagulation befraemjande verkan Download PDF

Info

Publication number
FI57421C
FI57421C FI772408A FI772408A FI57421C FI 57421 C FI57421 C FI 57421C FI 772408 A FI772408 A FI 772408A FI 772408 A FI772408 A FI 772408A FI 57421 C FI57421 C FI 57421C
Authority
FI
Finland
Prior art keywords
factor
feiba
activity
plasma
vii
Prior art date
Application number
FI772408A
Other languages
English (en)
Finnish (fi)
Other versions
FI772408A (fi
FI57421B (fi
Inventor
Johann Eibl
Otto Schwarz
Fritz Elsinger
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI772408A publication Critical patent/FI772408A/fi
Application granted granted Critical
Publication of FI57421B publication Critical patent/FI57421B/fi
Publication of FI57421C publication Critical patent/FI57421C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/28—Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
FI772408A 1976-08-30 1977-08-10 Foerfarande foer framstaellning av ett preparat ur maenniskoblodplasma med blodets koagulation befraemjande verkan FI57421C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT640576 1976-08-30
AT640576A AT350726B (de) 1976-08-30 1976-08-30 Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma

Publications (3)

Publication Number Publication Date
FI772408A FI772408A (fi) 1978-03-01
FI57421B FI57421B (fi) 1980-04-30
FI57421C true FI57421C (fi) 1980-08-11

Family

ID=3585985

Family Applications (1)

Application Number Title Priority Date Filing Date
FI772408A FI57421C (fi) 1976-08-30 1977-08-10 Foerfarande foer framstaellning av ett preparat ur maenniskoblodplasma med blodets koagulation befraemjande verkan

Country Status (17)

Country Link
US (1) US4160025A (da)
AR (1) AR213861A1 (da)
AT (1) AT350726B (da)
BE (1) BE858031A (da)
CA (1) CA1079191A (da)
CH (1) CH635747A5 (da)
DE (1) DE2734821C3 (da)
DK (1) DK151932C (da)
ES (1) ES461918A1 (da)
FI (1) FI57421C (da)
FR (1) FR2362633A1 (da)
GB (1) GB1554051A (da)
HU (1) HU180816B (da)
LU (1) LU78024A1 (da)
NL (1) NL170922C (da)
NO (1) NO148142C (da)
SE (1) SE443511B (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
JPH0686385B2 (ja) * 1980-01-28 1994-11-02 バクスタ−、インタ−ナショナル、インコ−ポレイテッド 活性プロトロンビン複合体組成物およびその製造方法
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
US4361510A (en) * 1980-05-27 1982-11-30 Cutter Laboratories, Inc. Blood coagulation promoting product
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
ATE15489T1 (de) * 1980-05-27 1985-09-15 Miles Lab Die blutkoagulation aktivierendes produkt und verfahren zu dessen herstellung.
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
US4391746A (en) * 1980-05-27 1983-07-05 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
US4382083A (en) * 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
US4479938A (en) * 1981-06-25 1984-10-30 Baxter Travenol Laboratories, Inc. Therapeutic composition containing factor VIIa
JPS5866054A (ja) * 1981-10-14 1983-04-20 Sekisui Chem Co Ltd 血液検査用容器
JPS58105064A (ja) * 1981-12-17 1983-06-22 Sekisui Chem Co Ltd 血液凝固促進剤
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
US5118614A (en) * 1988-01-18 1992-06-02 Tessek Sdruzeni Praha Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
JP3133338B2 (ja) * 1992-12-16 2001-02-05 イムノ・アクチエンゲゼルシャフト ウイルス的に安全な生物学的組成物の調製方法
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
US5677162A (en) * 1995-05-01 1997-10-14 New York Blood Center, Inc. Method for activating prothrombin to thrombin
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
DK0796623T3 (da) * 1996-03-20 2005-08-01 Baxter Ag Farmaceutisk præparat til behandling af blodkoagulationslidelser
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
RS20050051A (en) * 2002-07-23 2007-06-04 Bio-Products & Bio Engineering Ag., Pharmaceutical active ingredient preparation and medicaments that contain thrombin or have a thrombin-generating capacity
WO2004011023A1 (de) * 2002-07-23 2004-02-05 Bio-Products & Bio-Engineering Aktiengesellschaft Thrombingenerierfähige und thrombinhältige pharmazeutische wirkstoffzubereitungen und arzneimittel
EP2305289A1 (en) 2009-09-16 2011-04-06 Bio-Products & Bio-Engineering Aktiengesellschaft Medicinal products for the treatment of blood coagulation disorders
IS2809B (is) * 2011-03-08 2012-10-15 Haskoli Islands Blóðstorkumæling
RU2648517C1 (ru) * 2017-06-23 2018-03-26 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) Способ получения лиофилизированного препарата активированного протромбинового комплекса, обладающего фактор viii-шунтирующей активностью
WO2024012853A1 (de) 2022-07-12 2024-01-18 Biomedizinische Forschung & Bio-Produkte AG Arzneimittel zur förderung der hämostase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2262520B2 (de) * 1972-12-20 1979-10-11 Cutter Laboratories Inc., Berkeley, Calif. (V.St.A.) Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma
DE2459291C3 (de) * 1974-12-14 1981-06-04 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen
US3998946A (en) * 1975-04-23 1976-12-21 The Regents Of The University Of Minnesota Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same
DD121793A1 (da) * 1975-07-17 1976-08-20
US4027013A (en) * 1976-01-22 1977-05-31 William L. Wilson Clottable fibrinogen free factor VIII and albumin product and process

Also Published As

Publication number Publication date
FR2362633B1 (da) 1981-06-12
DK151932B (da) 1988-01-18
SE443511B (sv) 1986-03-03
DE2734821C3 (de) 1985-03-14
DE2734821B2 (de) 1980-11-06
NL7708872A (nl) 1978-03-02
BE858031A (fr) 1977-12-16
CA1079191A (en) 1980-06-10
NL170922B (nl) 1982-08-16
LU78024A1 (da) 1978-01-11
FI772408A (fi) 1978-03-01
CH635747A5 (de) 1983-04-29
FR2362633A1 (fr) 1978-03-24
ATA640576A (de) 1978-11-15
ES461918A1 (es) 1978-12-16
NO148142B (no) 1983-05-09
DK384577A (da) 1978-03-01
SE7707992L (sv) 1978-03-01
DE2734821A1 (de) 1978-03-02
US4160025A (en) 1979-07-03
GB1554051A (en) 1979-10-17
NO148142C (no) 1983-08-17
FI57421B (fi) 1980-04-30
NO772978L (no) 1978-03-01
NL170922C (nl) 1983-01-17
AR213861A1 (es) 1979-03-30
DK151932C (da) 1988-06-20
AT350726B (de) 1979-06-11
HU180816B (en) 1983-04-29

Similar Documents

Publication Publication Date Title
FI57421C (fi) Foerfarande foer framstaellning av ett preparat ur maenniskoblodplasma med blodets koagulation befraemjande verkan
EP0217341B2 (en) Process for preparing an anticoagulating substance
JP3055933B2 (ja) 改良された安定な凝固対照
US3717708A (en) Blood coagulation complex
US4404132A (en) Blood coagulation promoting product
US4849403A (en) Protein C activator, methods of preparation and use thereof
Didisheim et al. Preparation of a human plasma fraction rich in prothrombin, proconvertin, Stuart factor, and PTC and a study of its activity and toxicity in rabbits and man
JPH0650999B2 (ja) 血液凝固因子安定化法
FI101476B (fi) Menetelmä kalsiumista riippuvan proteiini C:n vastaisen monoklonaalise n vasta-aineen valmistamiseksi
JPS6028812B2 (ja) 副作用のない血漿分別物の製造方法
Odegaard et al. Protein C: an automated activity assay
Forbes et al. Studies on plasma thromboplastin antecedent (factor XI), PTA deficiency and inhibition of PTA by plasma: pharmacologic inhibitors and specific antiserum
US4081432A (en) Method of separating a Factor IX preparation from plasma using ethylene-maleic anhydride polymers
NATELSON et al. Acquired factor IX deficiency in the nephrotic syndrome
EP0044343A1 (en) THERAPEUTIC COMPOSITIONS CONTAINING PROTHROMBIN AND PROCESS FOR PRODUCING ENZYMATICALLY ACTIVE BLOOD COAGULATION FACTORS FROM BLOOD FRACTIONS CONTAINING PROTHROMBIN.
US4361510A (en) Blood coagulation promoting product
Suomela et al. Preparation and properties of a therapeutic factor IX concentrate
Spaet et al. Inactivation of thromboplastin in human blood
EP0041174B1 (en) Blood coagulation promoting product and process of preparing same
EP0052874A1 (en) Method for synthesizing procoagulant factor VIII activity
Wickerhauser et al. Development of Large-Scale Fractionation Methods
Chandra et al. Large scale preparation of nonthrombogenic prothrombin complex
Fantl et al. Comparison of blood clotting in marsupials and man.
Barrowcliffe et al. Studies of the heterogeneity of antithrombin III concentrates
Joist et al. Uroplastin, its nature and its excretion pattern in health and in certain disease states

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: "IMMUNO" AKTIENGESELLSCHAFT FUER